BOSTON , July 17, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has expanded its intellectual property portfolio following the receipt of a patent covering bioadhesive progressive hydration tablets.
LOS ANGELES , July 29, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB: MDBX) ( www.medbox.com ) (the "Company"), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, announced today that the company's founder has assigned any and all patents and patent applications, trademarks, and related intellectual property to Medbox, Inc. Previously, Medbox had been the exclusive licensee of these patents and IP.
U.S. Patent for Treatment of Second- and Third-Degree Burns; U.S. and Canadian Patents for Treatment of Peritonitis; Chinese Patent for Solution Containing Hypochlorous Acid and Its Methods of Use
PETALUMA, Calif., Sept.
Patents granted by the United States Patent and Trademark Office and European Patent Office and a notice of allowance from the Japanese Patent Office broaden the breadth of the Company's delivery technology platform
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.